SEC Form 4 · accession 0001104659-18-043597
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carrolee Barlow
Director
Period of report
Jun 27, 2018
Accepted (ET)
Jul 2, 2018 · 5:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $58.15 | Jun 27, 2018 | A | 10,213 | A | — | Jun 27, 2028 | Common Stock | 10,213 | 10,213 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on June 27, 2019.